SADA

Serial Number 88889313
Registration 6286299
700

Registration Progress

Application Filed
Apr 27, 2020
Under Examination
Approved for Publication
Dec 22, 2020
Published for Opposition
Dec 22, 2020
Registered
Mar 9, 2021

Trademark Image

SADA

Basic Information

Serial Number
88889313
Registration Number
6286299
Filing Date
April 27, 2020
Registration Date
March 9, 2021
Published for Opposition
December 22, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 9, 2021
Registration
Registered
Classes
005 042

Rights Holder

Y-mAbs Therapeutics, Inc

03
Address
230 Park Avenue, Suite 3350
New York, NY 10169

Ownership History

Y-mAbs Therapeutics, Inc

Original Applicant
03
New York, NY

Y-mAbs Therapeutics, Inc

Owner at Publication
03
New York, NY

Y-mAbs Therapeutics, Inc

Original Registrant
03
New York, NY

Legal Representation

Attorney
Andrew N. Spivak

USPTO Deadlines

Next Deadline
427 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210309)
Due Date
March 09, 2027
Grace Period Ends
September 09, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

17 events
Date Code Type Description Documents
Mar 9, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 22, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 22, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 2, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 19, 2020 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Nov 13, 2020 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Nov 12, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 12, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 12, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 4, 2020 ALIE A ASSIGNED TO LIE Loading...
Sep 10, 2020 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jul 20, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 20, 2020 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jul 20, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 17, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 8, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 30, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
Class 042
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies

Classification

International Classes
005 042